Teva’s Copaxone gets Japanese approval for multiple sclerosis relapse prevention

The Japanese Ministry of Health, Labour and Welfare (MHLW) has granted approval for Israel-based Teva Pharmaceutical Industries' once-daily Copaxone (glatiramer acetate injection) 20mg injection for prevention of multiple sclerosis relapse.
Source: Pharmaceutical Technology - Category: Pharmaceuticals Source Type: news